You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

7 Results
Guidelines and Advice
Status: Archived
ID: GL 11-11
Jul 2012
Guidelines and Advice
Status: Current
ID: 12-14
May 2012
Guidelines and Advice
Status: Archived
ID: DICRC
Sep 2012
Guidelines and Advice
Status: Archived
ID: DILung
Apr 2012
Guidelines and Advice
Status: Current
Dec 2012
Regimen
Cancer Type:
Hematologic, 
Leukemia - Acute Myeloid (AML)
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative
Funding:
Exceptional Access Program
    First-line treatment of adult patients diagnosed with FLT3-mutated acute myeloid leukemia, in combination with specific standard induction followed by consolidation chemotherapy, according to clinical criteria
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
cytarabine,
midostaurin
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Oct 2018
Guidelines and Advice
Status: In-Review
ID: ES 15-16
Oct 2018